Sugi Predict

Sugi Predict / Compounds / SCHEMBL2214348

SCHEMBL2214348

SCHEMBL2214348

CCCCCCCCOC(=O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 2/20 0.55
▸ TSHR P16473 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ LMNA P02545 1/20 0.53
▸ ALPI P09923 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ PTGS1 P23219 1/20 0.51
▸ XIAP P98170 1/20 0.51
▸ SLC7A5 Q01650 1/20 0.51
▸ CSNK1E P49674 1/20 0.51
▸ CYP3A4 P08684 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ DAGLA Q9Y4D2 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL973643 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL22654084 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL2804085 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL11220049 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL21585495 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL22654085 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL7780482 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL14965068 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL2214344 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI
SCHEMBL7780483 1.00 TYR (0.55) TYRTSHRALDH1A1LMNAALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180311316-A1 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 ADOCIA (FR) 2018-11-01 — — US claimed
US-20170182131-A9 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 ADOCIA (FR) 2017-06-29 — — US claimed
CN-103889442-B Injectable solution of at least one basal insulin 阿道恰公司 2016-12-28 — — CN claimed
EP-2741765-B9 INJECTABLE SOLUTION OF AT LEAST ONE TYPE OF BASAL INSULIN ADOCIA (FR) 2016-09-28 — — EP claimed
EP-2741765-B1 INJECTABLE SOLUTION OF AT LEAST ONE TYPE OF BASAL INSULIN ADOCIA (FR) 2016-03-30 — — EP claimed
US-20150250858-A1 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 ADOCIA (FR) 2015-09-10 — — US claimed
US-9089476-B2 Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5 ADOCIA (FR) 2015-07-28 — — US claimed
CN-103889442-A Injectable solution of at least one basal insulin ADOCIA 2014-06-25 — — CN claimed
US-20130065826-A1 Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 ADOCIA (FR) 2013-03-14 — — US claimed
US-20120309680-A1 Functionalized oligosaccharides ADOCIA (FR) 2012-12-06 — — US claimed
US-20240182510-A1 Compounds Useful in HIV Treatment VIIV HEALTHCARE COMPANY (US) 2024-06-06 — — US disclosed
WO-2024062180-A1 BIOSOURCED ORGANOGELATORS AND ORGANOGELS CONTAINING SAME SORBONNE UNIVERSITE (FR) 2024-03-28 — — WO disclosed
EP-4298105-A1 COMPOUNDS USEFUL IN HIV TREATMENT VIIV Healthcare Company (US) 2024-01-03 — — EP disclosed
US-20230255202-A1 ANTIMICROBIAL COMPOSITION THE PROCTER & GAMBLE COMPANY 2023-08-17 — — US disclosed
US-20230255202-A1 ANTIMICROBIAL COMPOSITION THE PROCTER & GAMBLE COMPANY 2023-08-17 — — US disclosed
CN-101048139-A Compositions for controlled delivery of pharmaceutically active compounds IDEXX LAB INC (US) 2007-10-03 — — CN disclosed
CN-1671654-A Gelling agent APPLIED NANOSYSTEMS BV (NL) 2005-09-21 — — CN disclosed
EP-1506168-A2 GELLING AGENTS Applied NanoSystems B.V. (NL) 2005-02-16 — — EP disclosed
WO-2003097587-A2 GELLING AGENTS APPLIED NANOSYSTEMS B.V. (NL) 2003-11-27 — — WO disclosed
EP-1364941-A1 Gelling agents Applied NanoSystems B.V. (NL) 2003-11-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170182131-A9 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 IAPP, IGFBP5, INSR TYR 3613/4885TSHR 1361/4885ALDH1A1 3807/4885
US-20230255202-A1 ANTIMICROBIAL COMPOSITION ARG1, CUTA, SLC7A1 TYR 1133/4885TSHR 3822/4885ALDH1A1 4465/4885
US-20180311316-A1 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 IAPP, IGFBP5, INSR TYR 3613/4885TSHR 1361/4885ALDH1A1 3807/4885
US-20150250858-A1 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 IAPP, IGFBP5, INSR TYR 3613/4885TSHR 1361/4885ALDH1A1 3807/4885
US-20120309680-A1 Functionalized oligosaccharides OSTC, STT3A, DDOST TYR 4476/4885TSHR 2480/4885ALDH1A1 2805/4885
US-20130065826-A1 Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 IAPP, IGFBP5, INSR TYR 3613/4885TSHR 1361/4885ALDH1A1 3807/4885
US-20240182510-A1 Compounds Useful in HIV Treatment CCR5, G6PD, NPC1 TYR 2876/4885TSHR 4867/4885ALDH1A1 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.